Skip to main content
Clinical Trials/NCT01451697
NCT01451697
Completed
Early Phase 1

Cognitive Remediation for Neuropsychological Impairment in Compulsive Hoarding

Hartford Hospital1 site in 1 country20 target enrollmentJuly 2011

Overview

Phase
Early Phase 1
Intervention
Not specified
Conditions
Hoarding Disorder
Sponsor
Hartford Hospital
Enrollment
20
Locations
1
Primary Endpoint
Continuous Performance Task (computerized version): change from Baseline in Attentional Functioning at 8 Weeks
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

The primary aim of this pilot randomized controlled trial is to examine whether cognitive remediation, compared to a placebo, improves attention and related cognitive functions in patients with compulsive hoarding. The primary hypothesis is that compulsive hoarding patients who are treated with cognitive remediation will demonstrate improved cognitive skills at post-treatment compared to patients receiving placebo. This will be especially true of attention; memory and executive function skills may also be improved.

Detailed Description

The primary aim of this pilot randomized controlled trial is to examine whether cognitive remediation, compared to a placebo, improves attention and related cognitive functions in patients with compulsive hoarding. Previous research has demonstrated that hoarders have diminished neuropsychological abilities, particularly in the areas of attention, memory, and executive function; and that cognitive remediation improves those functions in populations that are similarly impaired, such as in individuals with schizophrenia. The investigators will thus randomize 20 patients with compulsive hoarding to receive either cognitive remediation or a placebo condition. Before and after treatment, the investigators aim to assess the effects of cognitive remediation on neuropsychological functioning and hoarding severity. The primary specific aim is to examine whether cognitive remediation improves cognitive function in compulsive hoarders. The investigators hypothesize that compulsive hoarding patients who are treated with cognitive remediation will demonstrate improved cognitive skills at post-treatment compared to patients receiving placebo. This will be especially true of attention; memory and executive function skills may also be improved. A secondary, exploratory aim is to examine whether cognitive remediation improves hoarding severity, compared to placebo. The ultimate goal of this research is to determine the feasibility and appropriateness of pursuing larger-scale studies of the promising new approach of combining cognitive remediation with other treatments for compulsive hoarding-particularly cognitive-behavioral therapy (CBT).

Registry
clinicaltrials.gov
Start Date
July 2011
End Date
October 2012
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • be over 18 years of age,
  • have a current primary diagnosis of hoarding disorder
  • have no untreated and/or unstable concurrent psychiatric diagnoses
  • have a score on the ADHDSS that is one standard deviation or more above the mean
  • have an Attentional Composite score on the computerized battery of neuropsychological tests (Doniger, 2010) that is one standard deviation or more below the mean
  • be stable on all psychotropic medications during and up to four weeks preceding enrollment in the study

Exclusion Criteria

  • currently taking any cognitive enhancers or stimulants
  • people with a history of Multiple Sclerosis, Traumatic Brain Injury, loss of consciousness lasting more than 5 minutes, seizures, dementia, or other organic brain-related disorders
  • current Alcohol or Substance Abuse and/or a history of Alcohol or Substance Dependence

Outcomes

Primary Outcomes

Continuous Performance Task (computerized version): change from Baseline in Attentional Functioning at 8 Weeks

Time Frame: Week 0 (Baseline) and Week 8 (Endpoint)

This measure is a computerized assessment of attention, memory, and executive functioning. The investigators will use this measure to assess change in those cognitive domains between Baseline (Week 0) and Endpoint (Week 8).

Study Sites (1)

Loading locations...

Similar Trials